Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

INDUSTRY CONFIDENTIALITY CONCERNS MAY ARISE FROM AIDS DRUG DEVELOPMENT TASK FORCE SURVEY; WORKSHOP ON MOVING DRUGS INTO PHASE I TO BE HELD BY YEAR-END

Executive Summary

Certain questions for industry in the survey of AIDS drag discovery efforts being developed by the National Task Force on AIDS Drug Development could be difficult for manufacturers to answer due to confidentiality concerns, task force member and Bristol-Myers Squibb Senior VP-Clinical R&D Stephen Carter, MD, said at the July 18 task force meeting.
Advertisement
Advertisement
UsernamePublicRestriction

Register

PS024812

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel